Shopping Cart
Remove All
Your shopping cart is currently empty
PS10 is a broad-spectrum PDK inhibitor that inhibits PDK2, PDK4, PDK1, and PDK3. It significantly increases pyruvate dehydrogenase complex activity, and is used in research on obesity and type 2 diabetes.


| Description | PS10 is a broad-spectrum PDK inhibitor that inhibits PDK2, PDK4, PDK1, and PDK3. It significantly increases pyruvate dehydrogenase complex activity, and is used in research on obesity and type 2 diabetes. |
| Targets&IC50 | PDK4:0.76 μM, PDK1:21.3 μM, PDK3:2.1 μM, PDK2:0.8 μM |
| In vitro | PS10 is a pan-PDK inhibitor with IC50 of 0.8 μM, 0.76 μM, 2.1 μM and 21.3 μM for PDK2, PDK4, PDK1 and PDK3, respectively. The Kd value combined with PDK2 is 239 nM. [1] |
| In vivo | PS10 (70 mg/kg/ day for 3 days) stimulated PDC activity in DIO mice, increased glucose tolerance and reduced hepatic steatosis in DIO mice. [1] PS10 (70 mg/kg/ day, 4 weeks, intraperitoneal injection), mice showed significant improvements in glucose, insulin, and pyruvate tolerance, lower plasma insulin levels, and increased liver insulin signaling. [2] |
| Synonyms | PS 10 |
| Molecular Weight | 323.32 |
| Formula | C14H13NO6S |
| Cas No. | 1564265-82-2 |
| Smiles | O=S(=O)(C1=CC=C(O)C=C1O)N2CC=3C=C(O)C=C(O)C3C2 |
| Relative Density. | 1.696 g/cm3 (Predicted) |
| Color | Brown |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (154.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (15.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.